急性焦磷酸钙晶体关节炎经秋水仙碱与泼尼松治疗后缓解相关患者特征:随机对照试验的事后分析
该研究为COLCHICORT试验的事后分析,纳入89例急性焦磷酸钙晶体关节炎患者,比较秋水仙碱与泼尼松治疗。89例中43例(48.3%)为明确应答者;腕关节急性关节炎与第3天关节炎缓解相关,秋水仙碱组和利尿剂使用与治疗反应不佳相关。秋水仙碱组胃肠道不良事件中,男性与糖尿病似有保护作用,他汀使用似与事件发生相关。
要点
- 89例中43例(48.3%)为明确应答者
- 腕关节急性关节炎与第3天关节炎缓解相关(OR 4.06)
- 秋水仙碱组与治疗反应不佳相关(OR 0.31)
核心结论
- 该研究识别了急性焦磷酸钙晶体关节炎经秋水仙碱和泼尼松治疗后明确应答的相关因素,秋水仙碱与较差的疗效相关,且药物与相关疾病对其安全性和疗效存在双重影响。
研究设计与样本
- COLCHICORT试验的事后分析,比较秋水仙碱与泼尼松治疗急性焦磷酸钙晶体关节炎,共89例参与者,采用多重逻辑回归和决策树两种机器学习方法识别与疗效结局相关的独立因素。
主要发现
- 89例中43例(48.3%)为明确应答者。
- 单变量分析中,明确应答者更常因卒中住院(43例中9例;P=0.04)、年龄≥80岁(43例中39例;P=0.045)及血脂异常(43例中25例;P=0.03),而反应不佳者更常因急性关节炎发作住院(43例中22例;P<0.001)。
- 多重逻辑回归中,腕关节急性关节炎与第3天关节炎缓解相关(OR 4.06,95%CI 1.21-15.50.85),随机分入秋水仙碱组(OR 0.31,95%CI 0.11-0.83)和利尿剂使用(OR 0.23,95%CI 0.097-0.95)与治疗反应不佳相关。
- 决策树选择因急性关节炎住院、C反应蛋白水平和估算肾小球滤过率作为预测明确发作缓解的关键节点。
- 秋水仙碱胃肠道不良事件的多重逻辑回归模型中,男性(OR 0.33,95%CI 0.07-1.29)和糖尿病(OR 0.24,95%CI 0.030-1.24)似有保护作用,他汀使用(OR 3.54,95%CI 0.83-18.82)似与事件发生相关。
关键数值与推荐
- 明确应答者:43 of 89(48.3%)。
- 腕关节急性关节炎与关节炎缓解的OR 4.06(95%CI 1.21-15.50.85)。
- 秋水仙碱组与治疗反应不佳的OR 0.31(95%CI 0.11-0.83)。
- 利尿剂使用与治疗反应不佳的OR 0.23(95%CI 0.097-0.95)。
- 秋水仙碱胃肠道不良事件:男性OR 0.33(95%CI 0.07-1.29),糖尿病OR 0.24(95%CI 0.030-1.24),他汀使用OR 3.54(95%CI 0.83-18.82)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective was to identify factors determining acute arthritis resolution and safety with colchicine and prednisone in acute calcium pyrophosphate (CPP) crystal arthritis. METHODS: We conducted a post hoc analysis of the COLCHICORT trial, which compared colchicine and prednisone for the treatment of acute CPP crystal arthritis, using a composite outcome of secondary endpoints of the primary analysis. Factors associated with the sustained arthritis resolution with prednisone or colchicine treatment on day three, and the occurrence of gastrointestinal adverse events (AEs) with colchicine, were examined. Two different machine-learning approaches were used to identify independent factors associated with the efficacy outcome: multiple logistic regressions and a decision tree were used. RESULTS: In total, 43 of 89 (48.3%) of participants were considered definite responders. In univariable analysis, definitive responders were more often hospitalized for stroke (9 of 43; P = 0.04), had an age ≥80 years old (39 of 43; P = 0.045), and were dyslipidemic (25 of 43; P = 0.03), whereas poor responders were more commonly hospitalized to manage the acute arthritis episode (22 of 43; P < 0.001) In multiple logistic regression, acute arthritis of the wrists (odds ratio [OR] 4.06, 95% confidence interval [CI] 1.21-15.50.85) were associated with arthritis resolution on day three, whereas randomization in the colchicine arm (OR 0.31, 95% CI 0.11-0.83) and diuretic use (OR 0.23, 95% CI 0.097-0.95) were associated with a poor treatment response. Hospital admission for acute arthritis, C-reactive protein levels, and estimated glomerular filtration rate were decision tree nodes selected as crucial for predicting definitive flare resolution. Three candidate variables were identified in the multiple logistic regression model explaining the occurrence of gastrointestinal AEs with colchicine: male sex (OR 0.33, 95% CI 0.07-1.29) and diabetes (OR 0.24, 95% CI 0.030-1.24) seemed protective, whereas statin use (OR 3.54, 95% CI 0.83-18.82) seemed associated with their occurrence. CONCLUSION: This study identified factors associated with the definitive response to colchicine and prednisone treatment in acute CPP crystal arthritis. Colchicine was associated with poorer efficacy and was impacted by a dual effect on its safety and efficacy by medications and associated conditions.
引用
- Pascart T, Norberciak L, Richette P, et al. Exploring Patients' Profiles Associated With the Resolution of Acute Calcium Pyrophosphate Arthritis Treated With Colchicine and Prednisone: Post Hoc Analysis of a Randomized Controlled Trial. Arthritis Care Res (Hoboken). 2025. PMID: 40897521. doi:10.1002/acr.25642
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。